SPONSOR
OHSU Knight Cancer Institute
Total Trials
5
Recruiting
5
Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2
Conditions studied: Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmMalignant Brain NeoplasmLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Unresectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma
NCT06562777
Recruiting
Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
Hematopoietic and Lymphatic System Neoplasm
NCT03649880 Phase 2
Recruiting
Feasibility of FMISO in Brain Tumors
Malignant Brain Neoplasm
NCT04005690 EARLY_Phase 1
Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Locally Advanced Pancreatic Ductal Adenocarcinoma
NCT06673095
Recruiting
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8
NCT06357676 Phase 1, Phase 2
Recruiting
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial
Mantle Cell Lymphoma